Trials / Unknown
UnknownNCT06334406
Antitumor T Cell Responses in Patients With Bladder Cancer
Study of Antitumor T Cell Immune Responses in Patients With Bladder Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to evaluate the induction of Th1 anti-TERT responses by treatments in patients with bladder tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biological samples | Blood samples will be collected at baseline, after the diagnostic TURBT, and D15 after the end of treatment in each cohort. Tumor tissues will be collected at baseline for three patients. |
Timeline
- Start date
- 2024-04-02
- Primary completion
- 2026-04-02
- Completion
- 2026-04-02
- First posted
- 2024-03-28
- Last updated
- 2024-03-28
Source: ClinicalTrials.gov record NCT06334406. Inclusion in this directory is not an endorsement.